Articles Tagged “Drug Discovery”
6 articles found
Life Sciences Verification Opens Claude to Bio Labs
Anthropic's Life Sciences Verification Program gives vetted research teams Claude access tuned for biology, with monitoring replacing live blocking.
Rare Disease Research Grants Offer $50K in Claude Credits
Anthropic's AI for Science program offers rare disease researchers up to $50,000 in Claude credits over six months, with applications closing August 2.
Claude Science: An AI Workbench Built for Reproducible Research
Anthropic's new AI workbench unifies scientific tools, checks citations, and renders 3D proteins, promising reproducible, auditable research for every paid user.
Anthropic's Claude Science: An AI Workbench Built for Researchers
Anthropic's Claude Science is an AI research workbench that unifies scientific tools and prioritizes full reproducibility, from genomics to drug discovery.
AI Finds 1,000+ Antibiotic Candidates Hidden Inside Prion Proteins
Penn's APEX AI scanned prion proteins and surfaced over 1,000 antibiotic candidates on June 22, 2026 — two cleared infections in mice. A genuine AI-for-science win.
OpenAI's GPT-Rosalind Gets Faster, Cheaper, and Opens to Researchers Worldwide
OpenAI upgraded GPT-Rosalind, its drug-discovery and genomics model, on June 3, 2026 — cutting tokens 31% and opening the research preview to eligible organizations worldwide.